3rd Quarter - Report — MERCK & CO, INC. for MERCK & CO INC (2025)

Firm

MERCK & CO, INC.

Client

MERCK & CO INC

Income

—

Expenses

$1,520,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1, One Big Beautiful Bill, issues related to health care S. 1339, Pharmacy Benefit Manager Reform Act S. 2076, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2021 Issues relating to, 340B program integrity; 340B of the Public Health Services Act; 340B issues; 340B drug pricing program; Drug pricing; Drug pricing and reimbursement issues; Cost and value of medicines; Vaccine issues; Package inserts and e-labeling Package inserts, labeling issues, and e-labeling authorization legislation; Pharmaceutical supply channel issues; Drug shortages issues; Inflation Reduction Act (P.L. 117-169), issues relating to drug pricing provisions; FY-2026 Budget and Appropriations Legislation; Budget reconciliation drug pricing provisions; Commerce Justice, Science, and related agencies appropriations legislation for 2026; Interior, Environment, and related agencies appropriations legislation for 2026; Intellectual property protection and trade issues; Animal Health Policy Issues; Animal Drug User Fee Act (ADUFA) & Funding for Electronic Animal Traceability; General pharmaceutical issues; Vaccine Injury Compensation Program (VICP); Pharmacy Benefit Manager (PBM) policy issues; Pharmacy Benefit Manager reforms; Food and Drug Administration issues; Public Health Issues; Most Favored Nation (MFN) drug pricing.

Lobbyist	Covered position, as disclosed
ERIN DARLING	—
STEPHANIE MCBATH	—
BRADLEY ALLEN ROSSIN	—
ELIZABETH SCHWARTZ	—
BRADFORD TALLAMY	—

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: S. 1339 (119th), S. 2076 (119th), H.R. 1 (119th)

Medicare/Medicaid MMM

H.R. 1, One Big Beautiful Bill, issues related to health care Issues relating to, Medicare; Medicare Part B and D drug pricing issues; 340B program integrity; 340B of the Public Health Services Act; 340B drug pricing program; Drug pricing; Medicaid drug rebate program Cost and value of medicines: Drug pricing and reimbursement issues; FY-2026 Budget and Appropriations Legislation; Medicaid drug rebate program (MDRP).

Lobbyist	Covered position, as disclosed
ERIN DARLING	—
BRADLEY ALLEN ROSSIN	—
ELIZABETH SCHWARTZ	—
BRADFORD TALLAMY	—

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1 (119th)

Taxation/Internal Revenue Code TAX

Issues relating to, Tax reform and tax policy, generally; Inflation Reduction Act (P.L. 117-169), provisions relating to budget reconciliation and taxes.

Lobbyist	Covered position, as disclosed
BRADLEY ALLEN ROSSIN	—
ELIZABETH SCHWARTZ	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Animals ANI

Issues relating to, S. 1163, Rural Veterinary Workforce Act Agriculture; Animal Health Technology; Animal Health Policy Issues; Animal Drug User Fee Act (ADUFA) & Funding for Electronic Animal Traceability; Rural development; Administration and related agencies appropriations bill, FY-26.

Lobbyist	Covered position, as disclosed
STEPHANIE MCBATH	—
BRADLEY ALLEN ROSSIN	—

Contacted: SENATE; Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES

Bills named: S. 1163 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.